Aptahem to start toxicology programme for Apta-1
2018-05-15
Aptahem AB (publ.), a biotech company that develops aptamer-based drugs for the treatment of life-threatening conditions in which coagulation and inflammation interact in the disease process, can today announce that it will start its first toxicology trials this week....
Read More